{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T13:15:30Z","timestamp":1780060530999,"version":"3.54.0"},"reference-count":66,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2015,2,1]]},"abstract":"<jats:p>For those with severe alopecia areata, with greater than 50% scalp involvement, topical immunotherapy with diphenylcyclopropenone or squaric acid dibutylester is considered the treatment of choice. This article not only reviews the safety and efficacy of topical sensitizers for the treatment of alopecia areata but also highlights strides that have been made in the literature concerning their use in pediatric populations, molecular mechanisms of efficacy, and improved safety through targeted delivery methods.<\/jats:p>","DOI":"10.1097\/der.0000000000000094","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T00:46:52Z","timestamp":1421023612000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment of Alopecia Areata With Topical Sensitizers"],"prefix":"10.1177","volume":"26","author":[{"given":"Lesley","family":"Sutherland","sequence":"first","affiliation":[{"name":"From the Department of Dermatology, University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Laschinger","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain U.","family":"Syed","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Gaspari","sequence":"additional","affiliation":[{"name":"From the Department of Dermatology, University of Maryland School of Medicine, Baltimore."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/jid.1965.111","article-title":"Studies on the local administration of 2,3,5-tri-ethylene-imino-1,4,-benzoquinone to epitheliomas","volume":"45","author":"Helm F","year":"1965","unstructured":"Helm F, , Klein E, , Traenkle HL, et al. Studies on the local administration of 2,3,5-tri-ethylene-imino-1,4,-benzoquinone to epitheliomas. J Invest Derm, 1965; 45: 152\u2013159.","journal-title":"J Invest Derm"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0027-5107(71)90092-3","article-title":"Trenimon-induced chromosomal damage in bone-marrow cells of six mammalian species, evaluated by the micronucleus test","volume":"12","author":"Matter B","year":"1971","unstructured":"Matter B, , Schmid W. Trenimon-induced chromosomal damage in bone-marrow cells of six mammalian species, evaluated by the micronucleus test. Mutat Res, 1971; 12: 417\u2013425.","journal-title":"Mutat Res"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80450-8"},{"key":"e_1_3_1_5_2","first-page":"863","article-title":"Topical immunotherapy of refractory warts","volume":"12","author":"Lewis HM","year":"1973","unstructured":"Lewis HM. Topical immunotherapy of refractory warts. Cutis, 1973; 12: 863\u2013867.","journal-title":"Cutis"},{"issue":"3","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014Part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen EA","year":"2004","unstructured":"Olsen EA, , Hordinsky MK, , Price VH, et al. Alopecia areata investigational assessment guidelines\u2014Part II. National Alopecia Areata Foundation. J Am Acad Dermatol, 2004; 51 (3): 440\u2013447.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-5945-5-6","article-title":"Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population","volume":"5","author":"Aghaei S","year":"2005","unstructured":"Aghaei S. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. BMC Dermatol, 2005; 5: 6.","journal-title":"BMC Dermatol"},{"key":"e_1_3_1_8_2","first-page":"CD004413","article-title":"Interventions for alopecia areata","volume":"2","author":"Delamere FM","year":"2008","unstructured":"Delamere FM, , Sladden MM, , Dobbins HM, et al. Interventions for alopecia areata. Cochrane Database Syst Rev, 2008; 2:CD004413.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"e_1_3_1_9_2","first-page":"193","article-title":"Assay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis","volume":"141","author":"Pascher F","year":"1970","unstructured":"Pascher F, , Kurtin S, , Andrade R. Assay of 0.2 percent fluocinolone acetonide cream for alopecia areata and totalis. Efficacy and side effects including histologic study of ensuing localized acneform response. Dermatologica, 1970; 141 (3): 193\u2013202.","journal-title":"Efficacy and side effects including histologic study of ensuing localized acneform response. Dermatologica"},{"issue":"3","key":"e_1_3_1_10_2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.47102\/annals-acadmedsg.V38N3p276","article-title":"Vitiligo as an adverse reaction to topical diphencyprone","volume":"38","author":"Pan JY","year":"2009","unstructured":"Pan JY, , Theng C, , Lee J, et al. Vitiligo as an adverse reaction to topical diphencyprone. Ann Acad Med Singapore, 2009; 38 (3): 276\u2013277.","journal-title":"Ann Acad Med Singapore"},{"issue":"3","key":"e_1_3_1_11_2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1365-2133.1995.tb02692.x","article-title":"Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis","volume":"133","author":"Henderson CA","year":"1995","unstructured":"Henderson CA, , Ilchyshyn A. Vitiligo complicating diphencyprone sensitization therapy for alopecia universalis. Br J Dermatol, 1995; 133 (3): 496\u2013497.","journal-title":"Br J Dermatol"},{"issue":"3","key":"e_1_3_1_12_2","first-page":"196","article-title":"Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy","volume":"21","author":"Perrot CM","year":"1989","unstructured":"Perrot CM, , Steijlen PM, , Zaun H, et al. Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy. Contact Dermatitis, 1989; 21 (3): 196\u2013197.","journal-title":"Contact Dermatitis"},{"key":"e_1_3_1_13_2","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/14656560902876368","article-title":"Treatment strategies for alopecia areata","volume":"10","author":"Tosti A","year":"2009","unstructured":"Tosti A, , Duque-Estrada B. Treatment strategies for alopecia areata. Expert Opin Pharmacother, 2009; 10: 1017\u20131026.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"e_1_3_1_14_2","first-page":"1063","article-title":"Predictive model for immunotherapy of alopecia areata with diphencyprone","volume":"137","author":"Wiseman MC","year":"2001","unstructured":"Wiseman MC, , Shapiro J, , MacDonald N, et al. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol, 2001; 137 (8); 1063\u20131068.","journal-title":"Arch Dermatol"},{"issue":"1","key":"e_1_3_1_15_2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/0974-7753.66911","article-title":"Topical immunotherapy in alopecia areata","volume":"2","author":"Singh G","year":"2010","unstructured":"Singh G, , Lavanya M. Topical immunotherapy in alopecia areata. Int J Trichology, 2010; 2 (1): 36\u201339.","journal-title":"Int J Trichology"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3671"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2012.08.010"},{"issue":"1","key":"e_1_3_1_18_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/ja01510a060","article-title":"The synthesis of diphenylcyclopropenone","volume":"81","author":"Breslow R","year":"1959","unstructured":"Breslow R, , Haynie R, , Mirra J. The synthesis of diphenylcyclopropenone. J Am Chem Soc, 1959; 81 (1): 247\u2013248.","journal-title":"J Am Chem Soc"},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0190-9622(84)80456-9","article-title":"Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stability","volume":"11","author":"Wilkerson MG","year":"1984","unstructured":"Wilkerson MG, , Henkin J, , Wilkin JK. Diphenylcyclopropenone: examination for potential contaminants, mechanisms of sensitization, and photochemical stability. J Am Acad Dermatol, 1984; 11: 802\u2013807.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_20_2","first-page":"12","article-title":"Diphenylcyclopropenon\u2014ein stark wirksames Kontaktallergen","volume":"29","author":"Stute J","year":"1981","unstructured":"Stute J, , Hausen BM, , Schulz KH. Diphenylcyclopropenon\u2014ein stark wirksames Kontaktallergen. Dermatosen, 1981; 29: 12\u201315.","journal-title":"Dermatosen"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0190-9622(87)70244-8","article-title":"Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay","volume":"17","author":"Wilkerson MG","year":"1987","unstructured":"Wilkerson MG, , Connor TH, , Henkin J, et al. Assessment of diphenylcyclopropenone for photochemically induced mutagenicity in the Ames assay. J Am Acad Dermatol, 1987; 17: 606\u2013611.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_22_2","first-page":"S159","article-title":"Topical DPCP induces distinct early and late phase cellular immune reactions in human skin","volume":"133","author":"Gulati N","year":"2013","unstructured":"Gulati N, , Suarez-Farninas M, , Gilleaudeau P, et al. Topical DPCP induces distinct early and late phase cellular immune reactions in human skin. J Invest Dermatol, 2013; 133: S159\u2013S190.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_1_23_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0190-9622(85)70164-8","article-title":"Squaric acid and esters:analysis for contaminants and stability in solvents","volume":"13","author":"Wilkerson MG","year":"1985","unstructured":"Wilkerson MG, , Henkin K, , Wilkin JK, et al. Squaric acid and esters:analysis for contaminants and stability in solvents. J Am Acad Dermatol, 1985; 13: 229\u2013234.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_24_2","first-page":"256","article-title":"Alopecia areata (letter)","volume":"112","author":"Rosenberg E","year":"1976","unstructured":"Rosenberg E, , Drake L. Alopecia areata (letter). Arch Dermatol, 1976; 112: 256.","journal-title":"Arch Dermatol"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(77)92896-3","article-title":"Induction of hair growth in alopecia areata with DNCB","volume":"2","author":"Happle R","year":"1977","unstructured":"Happle R, , Echternacht K, Induction of hair growth in alopecia areata with DNCB. Lancet, 1977; 2: 1002\u20131003.","journal-title":"Lancet"},{"key":"e_1_3_1_26_2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1346-8138.2002.tb00199.x","article-title":"Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies","volume":"29","author":"Morita K","year":"2002","unstructured":"Morita K, , Nakamura M, , Nagamachi M, et al. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies. J Dermatol, 2002; 29: 661\u2013664.","journal-title":"J Dermatol"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0190-9622(98)70048-9","article-title":"Efficacy of topical sensitizers in treatment of alopecia areata","volume":"39","author":"Rokshar CK","year":"1998","unstructured":"Rokshar CK, , Shupack JL, , Vafai JJ, et al. Efficacy of topical sensitizers in treatment of alopecia areata. J Am Acad Dermatol, 1998; 39: 751\u2013761.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_28_2","first-page":"410","article-title":"Haptens as drugs: contact allergens are powerful topical immunomodulators","author":"Holzer AM","unstructured":"Holzer AM, , Kaplan LL, , Lewis WR. Haptens as drugs: contact allergens are powerful topical immunomodulators. J Drugs Dermatol 2006;, 5; 410\u2013416.","journal-title":"J Drugs Dermatol 2006;"},{"key":"e_1_3_1_29_2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nm0202-157","article-title":"CCL27-CCR10 interactions regulate T cell medicated skin inflammation","volume":"8","author":"Homey B","year":"2002","unstructured":"Homey B, , Alenius H, , Muller A, et al. CCL27-CCR10 interactions regulate T cell medicated skin inflammation. Nat Med, 2002; 8: 157\u2013165.","journal-title":"Nat Med"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05881.x"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70095-4"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.196"},{"key":"e_1_3_1_33_2","first-page":"25","volume":"149","author":"D\u2019Ovidio RAlopecia areata: news of diagnosis, pathogenesis, and treatment","year":"2014","unstructured":"D\u2019Ovidio RAlopecia areata: news of diagnosis, pathogenesis, and treatment. Ital J Dermatol Venereol, 2014; 149: 25\u201345.","journal-title":"Ital J Dermatol Venereol"},{"issue":"5","key":"e_1_3_1_34_2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2133.1991.tb00643.x","article-title":"Alopecia areata and topical sensitizers; allergic response is necessary but irritation is not","volume":"124","author":"Orecchia G","year":"1991","unstructured":"Orecchia G, , Perfetti L. Alopecia areata and topical sensitizers; allergic response is necessary but irritation is not. Br J Dermatol, 1991; 124 (5): 509.","journal-title":"Br J Dermatol"},{"issue":"3","key":"e_1_3_1_35_2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jaad.2009.01.027","article-title":"Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata","volume":"61","author":"Ochoa BE","year":"2009","unstructured":"Ochoa BE, , Sah D, , Wang G, et al. Instilled bimatoprost ophthalmic solution in patients with eyelash alopecia areata. J Am Acad Dermatol, 2009; 61 (3): 530\u2013532.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jaad.2006.02.045","article-title":"Alopecia in the United States: outpatient utilization and common prescribing pattern","volume":"57","author":"McMichael AJ","year":"2007","unstructured":"McMichael AJ, , Pearce DJ, , Wasserman D, et al. Alopecia in the United States: outpatient utilization and common prescribing pattern. J Am Acad Dermatol, 2007; 57: S49\u2013S51.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"e_1_3_1_37_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","article-title":"Alopecia areata","volume":"46","author":"Wasserman D","year":"2007","unstructured":"Wasserman D, , Guzman-Sanchez DA, , Scott K, et al. Alopecia areata. Int J Dermatol, 2007; 46 (2): 121\u2013123.","journal-title":"Int J Dermatol"},{"issue":"9","key":"e_1_3_1_38_2","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1468-3083.2006.01676.x","article-title":"Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease, and positive family history","volume":"20","author":"Goh C","year":"2006","unstructured":"Goh C, , Finkel M, , Christos PJ, et al. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease, and positive family history. J Eur Acad Dermatol Venereol, 2006; 20 (9): 1055\u20131060.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaad.2008.03.031","article-title":"The role of scalp dermoscopy in the diagnosis of alopecia areata incognita","volume":"59","author":"Tosti A","year":"2008","unstructured":"Tosti A, , Whiting D, , Iorizzo M, et al. The role of scalp dermoscopy in the diagnosis of alopecia areata incognita. J Am Acad Dermatol, 2008; 59: 64\u201367.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_40_2","first-page":"764","volume-title":"The Pigmentary System","author":"Westerhof W","year":"2006","unstructured":"Westerhof W, , Njoo D, , Menkes HE. Sudden whitening of hair. In: Nordlund JJ, , Boissy RE, , Hearing VJ, , King R, , Oetting W, et al., eds. The Pigmentary System. 2nd ed. Malden, MA: Blackwell; 2006: 764\u2013766.","edition":"2"},{"issue":"26","key":"e_1_3_1_41_2","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMra1103442","article-title":"Alopecia areata","volume":"366","author":"Gilhar A","year":"2012","unstructured":"Gilhar A, , Etzioni A, , Paus R. Alopecia areata. N Engl J Med, 2012; 366 (26): 1515\u20131525.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_42_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000296271","article-title":"Alopecia areata associated with localized vitiligo","volume":"2","author":"Kuchabal SD","year":"2010","unstructured":"Kuchabal SD, , Kuchabal DS. Alopecia areata associated with localized vitiligo. Case Rep Dermatol, 2010; 2: 27\u201331.","journal-title":"Case Rep Dermatol"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-4632.2005.01971.x","article-title":"Thyroid autoimmunity in children and adolescents with alopecia areata","volume":"44","author":"Kurtev A","year":"2005","unstructured":"Kurtev A, , Iliev E. Thyroid autoimmunity in children and adolescents with alopecia areata. Int J Dermatol, 2005; 44: 457\u2013461.","journal-title":"Int J Dermatol"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.04.031"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.09.014"},{"key":"e_1_3_1_46_2","first-page":"541","article-title":"Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?","volume":"66","author":"Paus R","year":"1993","unstructured":"Paus R, , Slominski A, , Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?. Yale J Biol Med, 1993; 66: 541\u2013554.","journal-title":"Yale J Biol Med"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700704"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.061206"},{"key":"e_1_3_1_49_2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0002-9440(10)63151-3","article-title":"Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair folicle as a model","volume":"164","author":"Ito T","year":"2004","unstructured":"Ito T, , Ito N, , Bettermann A, et al. Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair folicle as a model. Am J Pathol, 2004; 164: 623\u2013634.","journal-title":"Am J Pathol"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.jid.5701183","article-title":"Maintanance of hair follicle immune privilege is linked to prevention of NK cell attack","volume":"128","author":"Ito T","year":"2008","unstructured":"Ito T, , Ito N, , Saathoff M, et al. Maintanance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol, 2008; 128: 1196\u20131206.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1046\/j.0022-202x.2001.01583.x","article-title":"Melanocyte-associated T-cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice","volume":"117","author":"Gilhar A","year":"2001","unstructured":"Gilhar A, , Landau M, , Assy B, et al. Melanocyte-associated T-cell epitopes can function as autoantigens for transfer of alopecia areata to human scalp explants on Prkdc(scid) mice. J Invest Dermatol, 2001; 117: 1357\u20131362.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_1_52_2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2002.120604","article-title":"Persistent depigmented regrowth after alopecia areata","volume":"46","author":"Wade MS","year":"2002","unstructured":"Wade MS, , Sinclair RD. Persistent depigmented regrowth after alopecia areata. J Am Acad Dermatol, 2002; 46: 619\u2013620.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_53_2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mjd.2001.109309","article-title":"The use of topical diphencyclopropenone for the treatment of extensive alopecia areata","volume":"44","author":"Cotellessa C","year":"2001","unstructured":"Cotellessa C, , Peris K, , Caracciolo E, et al. The use of topical diphencyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol, 2001; 44: 73\u201376.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_54_2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1346-8138.1995.tb03936.x","article-title":"Alopecia areata in Korea","volume":"22","author":"Ro B","year":"1995","unstructured":"Ro B. Alopecia areata in Korea. J Dermatol, 1995; 22: 858\u2013864.","journal-title":"J Dermatol"},{"key":"e_1_3_1_55_2","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1038\/jid.1995.54","article-title":"Diphencyprone and minoxidil in alopecia areata: a clinical and immonopathological evaluation","volume":"104","author":"Shapiro J","year":"1995","unstructured":"Shapiro J, , Tan J, , Tron V. Diphencyprone and minoxidil in alopecia areata: a clinical and immonopathological evaluation. J Invest Dermatol, 1995; 104: S36.","journal-title":"J Invest Dermatol"},{"key":"e_1_3_1_56_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000247914","article-title":"Photochemotherapy plus squaric acid dibutylester in alopecia areata treatment [letter]","volume":"181","author":"Orecchia G","year":"1990","unstructured":"Orecchia G, , Perfetti L, et al. Photochemotherapy plus squaric acid dibutylester in alopecia areata treatment [letter]. Dermatologica, 1990; 181: 167.","journal-title":"Dermatologica"},{"key":"e_1_3_1_57_2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2230.1991.tb00339.x","article-title":"Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone","volume":"16","author":"Berth-Jones J","year":"1991","unstructured":"Berth-Jones J, , Hutchinson P. Treatment of alopecia totalis with a combination of inosine pranobex and diphencyprone compared to each treatment alone. Clin Exp Dermatol, 1991; 16: 172.","journal-title":"Clin Exp Dermatol"},{"key":"e_1_3_1_58_2","first-page":"62","article-title":"Hair regrowth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe","volume":"9","author":"Ali A","year":"2010","unstructured":"Ali A, , Martin JM. Hair regrowth in patients alopecia areata totalis after treatment with simvastatin and ezetimibe. J Drugs Dermatol, 2010; 9: 62\u201364.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_1_59_2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1001\/archdermatol.2012.1622","article-title":"The safety and efficacy of diphencyprone for the treatment of alopecia areata in children","volume":"148","author":"Donovan J","year":"2012","unstructured":"Donovan J, , Salsberg J. The safety and efficacy of diphencyprone for the treatment of alopecia areata in children. Arch Dermatol, 2012; 148: 1084\u20131085.","journal-title":"Arch Dermatol"},{"key":"e_1_3_1_60_2","first-page":"129","article-title":"Topical immunotherapy in alopecia areata:anamnestic for the treatment of extensive alopecia areata","volume":"192","author":"Weise K","year":"1996","unstructured":"Weise K, , Kretzschmar L, , John SM, , Hamm H. Topical immunotherapy in alopecia areata:anamnestic for the treatment of extensive alopecia areata. J Am Acad Dermatol, 1996; 192: 129\u2013133.","journal-title":"J Am Acad Dermatol"},{"key":"e_1_3_1_61_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.1997.03890400145035","article-title":"Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester","volume":"133","author":"Iijima S","year":"1997","unstructured":"Iijima S, , Otsuka F. Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester. Arch Dermatol, 1997; 133: 539\u2013540.","journal-title":"Arch Dermatol"},{"key":"e_1_3_1_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30254-7"},{"key":"e_1_3_1_63_2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0733-8635(18)30255-9","article-title":"Topical immunotherapy of alopecia areata","volume":"11","author":"Van der Steen PHM","year":"1993","unstructured":"Van der Steen PHM, , Happle R. Topical immunotherapy of alopecia areata. Dermatol Clin, 1993; 11: 619\u2013622.","journal-title":"Dermatol Clin"},{"key":"e_1_3_1_64_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2133.2001.04399.x","article-title":"The therapeutic use of topical contact sensitizers in benign dermatoses","volume":"145","author":"Buckley DA","year":"2001","unstructured":"Buckley DA, , Du Vivier AW. The therapeutic use of topical contact sensitizers in benign dermatoses. Brit J Dermatol, 2001; 145: 385\u2013405.","journal-title":"Brit J Dermatol"},{"key":"e_1_3_1_65_2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0733-8635(05)70400-9","article-title":"Topical immunotherapy in alopecia areata","volume":"14","author":"Hoffman R","year":"1996","unstructured":"Hoffman R, , Happle R. Topical immunotherapy in alopecia areata. What, how and why? Dermatol Clin, 1996; 14: 739\u2013744.","journal-title":"What, how and why? Dermatol Clin"},{"key":"e_1_3_1_66_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1046\/j.1365-2133.1996.119854.x","article-title":"Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months follow-up","volume":"13","author":"Gordon PM","year":"1996","unstructured":"Gordon PM, , Aldridge RD, , McVittie E, et al. Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months follow-up. Br J Dermatol, 1996; 13: 869\u2013871.","journal-title":"Br J Dermatol"},{"key":"e_1_3_1_67_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11095-012-0888-0","article-title":"Squalene-containing nanostructured lipid carries promote percutaneous absorption and hair follicle targeting for diphencyprone for treating alopecia areata","volume":"30","author":"Lin YK","year":"2013","unstructured":"Lin YK, , Al-Suwayeh SA, , Leu YL, et al. Squalene-containing nanostructured lipid carries promote percutaneous absorption and hair follicle targeting for diphencyprone for treating alopecia areata. Pharm Res, 2013; 30: 435\u2013446.","journal-title":"Pharm Res"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000094","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000094","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000094","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:03:25Z","timestamp":1777399405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2,1]]}},"alternative-id":["10.1097\/DER.0000000000000094"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000094","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}